Trabedersen to target transforming growth factor-β: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142)

Podobne zapisy

• Response to MC Chamberlain: Convection-enhanced delivery of transforming growth factor-β2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to W Wick and M Weller: Trabedersen to target transforming growth factor-β: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142)
  od: Bogdahn, Ulrich
  Wydane: (2011)
• Convection-enhanced delivery of a transforming growth factor-β2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142)
  od: Chamberlain, Marc C
  Wydane: (2011)
• Neuro-Oncology: Past Milestones and the Journey Ahead
  od: Alfred Yung, W.K.
  Wydane: (2013)
• Burnout and career satisfaction in neuro-oncology: a survey of the Society for Neuro-Oncology and the European Association of Neuro-Oncology memberships
  od: Yust-Katz, Shlomit, i wsp.
  Wydane: (2020)
• The journey is the reward
  od: Sathyanarayana Rao, T. S.
  Wydane: (2010)